Test Name	CFAP298 Gene Primary ciliary dyskinesia type 26 NGS Genetic DNA Test
Test type	ENT Doctor
Pre-test Information	Clinical History of Patient who is going for GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test gene GJB18
Report Delivery	3 to 4 Weeks
Components
Price	₹ 20000
Method	NGS Technology

Short Description

NGS genetic DNA test detecets for variant and mutation detection in CFAP298 gene for Primary ciliary dyskinesia type 26

PreTest Information

Clinical History of Patient who is going for GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test gene GJB18

Detail Description

CFAP298 Gene Primary Ciliary Dyskinesia Type 26 NGS Genetic DNA Test

Introduction

Primary ciliary dyskinesia (PCD) is a rare genetic disorder that affects the motility of cilia. Cilia are microscopic hair-like structures that line the respiratory tract, sinuses, and ears. They play a crucial role in clearing mucus and other substances from these areas. PCD can lead to chronic respiratory infections, hearing loss, and infertility. CFAP298 Gene Primary Ciliary Dyskinesia Type 26 is a specific type of PCD caused by mutations in the CFAP298 gene. NGS Genetic DNA Test can help in the diagnosis of this condition.

Symptoms of CFAP298 Gene Primary Ciliary Dyskinesia Type 26

The symptoms of CFAP298 Gene Primary Ciliary Dyskinesia Type 26 are similar to those of other types of PCD. These symptoms usually appear in infancy or childhood and can include:

• Chronic cough
• Recurrent respiratory infections
• Difficulty breathing
• Wheezing
• Nasal congestion
• Chronic sinus infections
• Ear infections
• Hearing loss
• Infertility

Diagnosis of CFAP298 Gene Primary Ciliary Dyskinesia Type 26

Diagnosing CFAP298 Gene Primary Ciliary Dyskinesia Type 26 can be challenging because its symptoms are similar to those of other respiratory conditions. A NGS Genetic DNA Test can help in the diagnosis of this condition. This test analyzes the DNA to look for mutations in the CFAP298 gene. A positive result indicates that the individual has CFAP298 Gene Primary Ciliary Dyskinesia Type 26.

Cost of CFAP298 Gene Primary Ciliary Dyskinesia Type 26 NGS Genetic DNA Test

The cost of CFAP298 Gene Primary Ciliary Dyskinesia Type 26 NGS Genetic DNA Test in India is INR 20,000. The cost may vary depending on the laboratory and location.

Conclusion

CFAP298 Gene Primary Ciliary Dyskinesia Type 26 is a rare genetic disorder that can lead to chronic respiratory infections, hearing loss, and infertility. NGS Genetic DNA Test can help in the diagnosis of this condition. The cost of CFAP298 Gene Primary Ciliary Dyskinesia Type 26 NGS Genetic DNA Test in India is INR 20,000. If you or your loved ones are experiencing any of the symptoms mentioned above, it is important to consult a healthcare provider. Early diagnosis and treatment can help improve the quality of life for individuals with CFAP298 Gene Primary Ciliary Dyskinesia Type 26.

CFAP298 (Cilia and Flagella Associated Protein 298) is a gene that is important for the proper function of cilia. Mutations in the CFAP298 gene can lead to defects in cilia movement, resulting in the development of Primary Ciliary Dyskinesia Type 26.

NGS (Next-Generation Sequencing) genetic DNA tests can be used to analyze the DNA sequence of genes like CFAP298 to identify any mutations or variants that may be associated with Primary Ciliary Dyskinesia Type 26.

If you or someone you know is considering genetic testing for Primary Ciliary Dyskinesia Type 26 related to the CFAP298 gene, I recommend consulting with a medical geneticist, a pulmonologist, or a genetic counselor. They can provide accurate and current information about the condition, the implications of genetic testing, and any available treatment or management options. Medical knowledge can evolve, so it's important to rely on expert guidance for the latest information.